In the face of new diseases, m.dicine needs to reinvent itself in order to contain and control ep.dem.cs, such as the one we have recently faced, COVID-19, a disease with a wide sp.ctrum.of clinical severity. A new m....
详细信息
In the face of new diseases, m.dicine needs to reinvent itself in order to contain and control ep.dem.cs, such as the one we have recently faced, COVID-19, a disease with a wide sp.ctrum.of clinical severity. A new m.m.nt has been established, since the ap.lication of well-known, effective and safe m.dications for other diseases, has shown high success rates in the treatm.nt of COVID-19. Thereunto, studies with early intervention are needed, which can change the unfavorable outcom. of p.tients. In this article, we rep.rt the successful exp.rience using an oral strategy during the collap.e of Belem.(p.ra, Brazil) Health System. Two hundred and ten p.tients were diagnosed with resp.ratory failure due to COVID-19, with no op.ion of hosp.tal treatm.nt due to lack of beds and resources. These p.tients were then started on therap.utic regim.n consisting of 40 m. p.ednisolone, 40 m. enoxap.rin and m.crolides (500 m. clarithrom.cin, 500 m. axetylcefuroxim.) associated and followed in outp.tient facilities. Two hundred and eight p.tients had an excellent therap.utic resp.nse and there were only two fatalities. These results p.sh research boundaries, valuing outp.tient treatm.nt with early use of p.ednisolone in the initial p.lm.nary p.ase, p.eventing severe COVID-19 p.eum.nitis. Adop.ion of the p.op.sed treatm.nt intends to reduce the need for hosp.talization, as well as lethality, with social robust benefits and incalculable econom.c savings since involves the use of accessible, safe and not exp.nsive m.dications.
暂无评论